WellDoc BlueStar vs AVIEW

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

WellDoc BlueStar

by WellDoc

AVIEW

by Coreline Soft Co.

AI Verdict

WellDoc BlueStar is a digital health solution focused on chronic disease management through personalized coaching and data integration for conditions like diabetes and heart failure. In contrast, AVIEW is an AI platform designed for diagnostic imaging analysis, specifically for the early detection and monitoring of conditions like lung cancer, COPD, and coronary artery calcification from CT scans. While both tools operate in healthcare and have a cardiology component, WellDoc targets patient engagement and ongoing care, whereas AVIEW is a radiology tool for diagnostic interpretation.

Choose WellDoc BlueStar if…

Choose WellDoc BlueStar if your organization aims to empower patients with chronic conditions like diabetes, hypertension, or heart failure through personalized, AI-driven coaching and real-time feedback. This tool is ideal for improving patient engagement and self-management by integrating data from various connected devices and providing actionable insights, including insulin dose recommendations, directly to the patient and their care team.

View WellDoc BlueStar →

Choose AVIEW if…

Choose AVIEW if your radiology department or healthcare facility requires advanced AI-powered solutions for the early detection, diagnosis, and monitoring of lung conditions and coronary artery calcification from CT scans. This platform is best suited for enhancing diagnostic precision, automating measurements like lung nodule characterization and CAC scoring, and streamlining radiology workflows through comprehensive 3D visualizations and integration with existing systems.

View AVIEW →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	WellDoc BlueStar	AVIEW
Pricing	Enterprise pricing; paid by health plans, health systems, or employers.	Subscription; one-off payment
Deployment	Mobile app (iOS, Android) and web-based platform	Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker)
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	WellDoc BlueStar	AVIEW
Primary Focus/Purpose	AI-powered digital health solution for chronic disease management, offering personalized coaching and insights for conditions like diabetes, hypertension, and heart failure.	AI platform for early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans.
Company	WellDoc	Coreline Soft Co.
Key AI Capabilities	AI-driven personalized coaching, multi-condition support, integration with connected devices, insulin dose recommendations, real-time feedback, care team portal, SMARTVisit reports.	AI-powered lung nodule detection and characterization, emphysema quantification, coronary artery calcium (CAC) scoring, automated segmentation, 3D visualizations, workflow automation.
Supported Specialties	Cardiology, Endocrinology, Internal Medicine	Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring WellDoc BlueStar and AVIEW.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications and target patient populations for WellDoc BlueStar and AVIEW?

WellDoc BlueStar is an AI-powered digital health solution for chronic disease management, offering personalized coaching and insights for conditions like diabetes, hypertension, and heart failure. It is intended for use by healthcare providers and their adult patients with type 1 or type 2 diabetes. AVIEW, on the other hand, is an AI platform that provides comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans.

Which medical specialties are these tools designed to support?

WellDoc BlueStar is designed to support specialties such as Cardiology, Endocrinology, and Internal Medicine. AVIEW is tailored for Cardiology, Pulmonology, and Radiology.

How do these tools integrate into a physician's existing clinical workflow?

WellDoc BlueStar offers a care team portal for providers (Management Portal) and generates SMARTVisit reports for healthcare providers, with integration capabilities into the EHR workflow to simplify connecting patients with their care team and provide real-time data access. AVIEW provides workflow automation and integration with PACS/RIS/CIS, generating 3D visualizations and comprehensive PDF reports from CT scan analysis to streamline radiology workflows.

What types of data do these tools primarily utilize and generate?

WellDoc BlueStar utilizes patient-logged data such as glucose, blood pressure, weight, sleep, meals, and exercise, and integrates with connected devices like BGMs, CGMs, BP cuffs, and activity trackers. It generates AI-driven personalized coaching and insights, including insulin dose recommendations. AVIEW processes CT scan data to generate AI-powered analyses for lung nodule detection and characterization, emphysema quantification, and coronary artery calcium scoring, producing 3D visualizations and comprehensive PDF reports.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring WellDoc BlueStar or AVIEW

Backers

Who funded each tool's parent company.